23 results on '"Grille S"'
Search Results
2. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): APPLICATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-M) MODEL IN SOUTH-AMERICAN MDS PATIENTS: A STUDY FROM ARGENTINA AND URUGUAY
3. Topic: AS02-Epidemiology: TP53 MYELODYSPLASTIC SYNDROMES IN LATIN AMERICA. REAL WORLD DATA FROM LATIN AMERICAN MDS GROUP (GLAM)
4. Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: GENE EXPRESSION PROFILE OF HUMAN MESENCHYMAL STROMAL CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS AND HEALTHY CONTROLS
5. Topic: AS08-Treatment/AS08a-Current treatment options – Higher risk MDS: VENETOCLAX AND AZACYTIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES, A REAL-WORLD EXPERIENCE. LATIN-AMERICAN MDS GROUP – GLAM
6. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): REAL-WORLD LABORATORY PRACTICE PATTERNS ON NEXT-GENERATION-SEQUENCING (NGS) TECHNOLOGY IN LATIN AMERICA
7. Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ARE WE READY TO PERFORM NGS FOR ALL MDS PATIENTS ?
8. P125 - Topic: AS08-Treatment/AS08a-Current treatment options – Higher risk MDS: VENETOCLAX AND AZACYTIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES, A REAL-WORLD EXPERIENCE. LATIN-AMERICAN MDS GROUP – GLAM
9. P083 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: GENE EXPRESSION PROFILE OF HUMAN MESENCHYMAL STROMAL CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS AND HEALTHY CONTROLS
10. P029 - Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ARE WE READY TO PERFORM NGS FOR ALL MDS PATIENTS ?
11. P023 - Topic: AS02-Epidemiology: TP53 MYELODYSPLASTIC SYNDROMES IN LATIN AMERICA. REAL WORLD DATA FROM LATIN AMERICAN MDS GROUP (GLAM)
12. P010 - Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): MOLECULAR PROFILE OF MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS. REAL WORLD DATA FROM ARGENTINA AND URUGUAY
13. P009 - Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): APPLICATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-M) MODEL IN SOUTH-AMERICAN MDS PATIENTS: A STUDY FROM ARGENTINA AND URUGUAY
14. P008 - Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): REAL-WORLD LABORATORY PRACTICE PATTERNS ON NEXT-GENERATION-SEQUENCING (NGS) TECHNOLOGY IN LATIN AMERICA
15. Flow Cytometry “Ogata Score” in Latin America. On Behalf of the Grupo Latinoamericano De Mielodisplasia (GLAM)
16. A Survey of the Current use of Flow Cytometry for the Diagnosis of Myelodysplastic Syndromes in Latin America
17. Lower-Risk Patients that Required Hypomethylating Agents. A Multicentric Experience from Latin America
18. 156 - Flow Cytometry “Ogata Score” in Latin America. On Behalf of the Grupo Latinoamericano De Mielodisplasia (GLAM)
19. 155 - A Survey of the Current use of Flow Cytometry for the Diagnosis of Myelodysplastic Syndromes in Latin America
20. 138 - Access to Diagnostic and Therapeutic Tools for Myelodysplastic Syndromes in General Practice: Survey Among South-American Hematologists
21. 95 - Higher Risk Patients Under Hypomethylating Agents – A Multicentric Experience from Latin America
22. 102 - Lower-Risk Patients that Required Hypomethylating Agents. A Multicentric Experience from Latin America
23. A therapeutic vaccine using Salmonella-modified tumor cells combined with interleukin-2 induces enhanced antitumor immunity in B-cell lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.